CELZ Creative Medical Technology Holdings, Inc.

-

Creative Medical Technology Missed Consensus Estimates

Friday, August 7, 2026 · 12:00 AM ET

Creative Medical Technology (CELZ) reported a loss of $0.41 per share on revenue of $0.00 million for the second quarter ended June 2026. The consensus estimate was a loss of $0.39 per share. The company missed consensus estimates by 5.13%.

Creative Medical Technology Holdings Inc. is a commercial stage biotechnology company focused on a regenerative approach to Immunotherapy, Urology, Neurology and Orthopedics. Creative Medical Technology Holdings Inc. is based in PHOENIX.

Earnings Whisper Grade
Power Rating
Reported Earnings
($0.41)
Earnings Whisper®
Consensus Estimate
($0.39)
Earnings Surprise
Earnings Growth14.6 %
Reported Revenue
Revenue Estimate
Revenue Surprise
Revenue Growth